Joyonna Gamble-George Explained

Joyonna Gamble-George
Education:Vanderbilt University (Ph.D.)
University of South Florida College of Public Health (MHA)
Xavier University of Louisiana (B.S.)

Joyonna Gamble-George is an American neuroscientist, innovator, and entrepreneur known for her research with the endocannabinoid system in stress-induced maladaptations of the brain.[1] She is an Adjunct Professor at St. Petersburg College, Florida.

Education

Gamble-George graduated from Eleanor Roosevelt High School of Greenbelt, Maryland with merit from the school's science and technology program.[1] Following graduation, Gamble-George attended Xavier University of Louisiana and joined the Alpha Kappa Alpha sorority.[1] She graduated cum laude with a Bachelor of Science in Biochemistry and Biology/Pre-Medicine and was the only student in her class to graduate with an Honors in Mathematics.[1] She then received a Master of Health Administration from the University of South Florida College of Public Health.[1] Gamble-George continued her education at Vanderbilt University where she earned a Doctor of Philosophy degree in Neuroscience.[2] She completed her postdoctoral training at the University of Florida, where she researched communication in the human brain and animal models of HIV-1 infection.[3]

Research

Gamble-George works in the fields of medical science and biotechnology, and has scientific publications concerning Alzheimer's disease pathology, anxiety and stress-related disorders, neurotoxicity, HIV, and therapeutics.[4] [5]

Gamble-George's first pre-baccalaureate research experience involved investigating the bonding structure between molybdenum in oxidation state six and amino acid type ligands in an effort to understand how molybdenum's involvement in the development of gout could prevent the disease from spreading.[6] As an undergraduate, she conducted research focused on palmetto and licorice root as a possible treatment for prostate cancer.[6]

At Bay Pines Veterans Affairs Healthcare System, Gamble-George investigated how Raf inhibitors could possibly assist neurological disorders, such as Alzheimer's disease, and as anti-neurodegenerative agents.[6] [7] Thereafter, she became involved in drug addiction research at Meharry Medical College and published research on the effects of methamphetamine on the brain.[1] [6] [8]

Gamble-George's PhD research focused on the endocannabinoid system with regard to anxiety and depression.[1] [9] [10]

At the University of Florida, she investigated the cellular mechanisms involved in drug addiction and HIV-1 infection.[6] [11] [12]

Career

Gamble-George worked at the National Institutes of Health National Heart, Lung, and Blood Institute as a health scientist and AAAS Science & Technology Policy Fellow.[13] [14] She served as an expert science advisor at NIH to advise others with their research on vulnerable populations.

Along with her research, Gamble-George worked as a healthcare administrator and health system specialist where she evaluated daily functions of Central Alabama Veterans Healthcare System.[1] During this time, she performed strategic planning and implementation to improve customer service, Veterans benefits, and patient hospital admission through a program sponsored by the American Hospital Association.[1]

She also co-founded SciX and now serves as a national team member for the company.[15] [16] SciX is a biotech development company aiming to create wearable devices that can predict heart related problems using artificial intelligence.[17]

She is an adjunct professor at St. Petersburg College in Pinellas County, Florida.[3] [18]

Personal life

Gamble-George grew up in rural Alabama on her grandparents' farm, located in an area where access to primary care was often challenging. She has stated that she believes these issues motivated her to pursue a career in healthcare.[1]

Awards and honors

Gamble-George has won awards and honors including the following:

Notes and References

  1. Web site: Episode 20: Joyonna Gamble-George, PhD. 2021-11-28. Conjugate: Illustration and Science Blog. en-US.
  2. Web site: Joyonna Gamble-George. 2021-11-08.
    1. BlackInSciComm
    . en-US.
  3. Web site: Dr. Joyonna Gamble-George Faculty Profile SPC. 2021-11-29. web.spcollege.edu.
  4. Web site: Joyonna Gamble-George, Co-Founder, Chief Operations Officer, and Chief Scientific and Medical Officer, SciX. 2021-11-24. www.topionetworks.com.
  5. Web site: gamble-george j - Search Results - PubMed. 2021-11-08. PubMed. en.
  6. Web site: 2017-05-04. Contributions to Science. 2021-11-25. Joyonna Gamble-George, Ph.D..
  7. Echeverria. Valentina. Burgess. Sarah. Gamble-George. Joyonna. Arendash. Gary W.. Citron. Bruce A.. 2008-10-17. Raf inhibition protects cortical cells against beta-amyloid toxicity. Neuroscience Letters. 444. 1. 92–96. 10.1016/j.neulet.2008.07.092. 0304-3940. 18706973. 33514296. 2022-02-02.
  8. North. Ashley. Swant. Jarod. Salvatore. Michael F.. Gamble-George. Joyonna. Prins. Petra. Butler. Brittany. Mittal. Mukul K.. Heltsley. Rebecca. Clark. John T.. Khoshbouei. Habibeh. May 2013. Chronic Methamphetamine Exposure Produces a Delayed, Long-Lasting Memory Deficit. Synapse (New York, N.Y.). 67. 5. 245–257. 10.1002/syn.21635. 0887-4476. 3831527. 23280858.
  9. Web site: Joyonna Gamble-George, Ph.D.. 2021-11-08. Vanderbilt University. en.
  10. Gamble-George. Joyonna Carrie. 2016-08-01. Endocannabinoid Augmentation Through Substrate-Selective COX-2 Inhibition: Behavioral and Synaptic Effects In An Animal Model of Stress-Induced Anxiety. en. ir.vanderbilt.edu. 2022-02-02.
  11. Miller. Douglas R.. Shaerzadeh. Fatemeh. Phan. Leah. Sharif. Nesrin. Gamble-George. Joyonna. McLaughlin. Jay P.. Streit. Wolfgang J.. Khoshbouei. Habibeh. September 2018. HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Glia. 66. 9. 1915–1928. 10.1002/glia.23447. 1098-1136. 6185750. 29733459.
  12. Gaskill. Peter J.. Miller. Douglas R.. Gamble-George. Joyonna. Yano. Hideaki. Khoshbouei. Habibeh. September 2017. HIV, Tat and dopamine transmission. Neurobiology of Disease. 105. 51–73. 10.1016/j.nbd.2017.04.015. 1095-953X. 5541386. 28457951.
  13. Web site: Member profile: Joyonna Gamble-George. 2023-01-22. ASCB. en-US.
  14. Web site: Innovating sickle cell disease education models . NIH National Heart, Lung, and Blood Institute . 2023-01-22. en-US.
  15. Web site: Team & Advisory Board. 2021-11-08. SciX. en-US.
  16. Web site: USF Magazine Winter 2020 by USF magazine - Issuu. 2021-11-29. issuu.com. en.
  17. Web site: Dr. Joyonna Gamble-George. 2021-11-08. Wonder Women Tech. en-US.
  18. Web site: Joyonna Gamble-George - Adjunct Professor in the Natural Sciences Department at St. Petersburg College - Wiza. 2021-11-29. wiza.co.
  19. Web site: ICRS2014 - The 24th International Cannabinoid Research Society Symposium 2014 Awardees. 2021-11-29. icrs.co.
  20. Web site: ASPPH South Florida Alumna Selected to Attend Lindau Nobel Laureate Meeting. 2021-11-29. www.aspph.org.
  21. Web site: 2019-01-14. Small Business Expo Reveals Winners for 2018 Best of Small Business Awards™. 2021-11-29. Small Business Expo. en-US.
  22. Web site: 125 Women in STEM Selected as AAAS IF/THEN Ambassadors American Association for the Advancement of Science. 2021-11-29. www.aaas.org. en.
  23. Web site: 2019-06-13. NSBA Names Joyonna Gamble-George Finalist for Advocate of the Year Award. 2021-11-29. National Small Business Association. en-US.
  24. Web site: From Coke Florida to the Buccaneers, this year's 40 Under 40 honorees span many industries. 2021-11-29. www.bizjournals.com.
  25. July 2000. SSL certificate validation vulnerability. Network Security. 2000. 7. 3. 10.1016/s1353-4858(00)07005-7. 1353-4858. 2022-02-02.
  26. Web site: 2021 OD Awards NIH Director's Awards . 2022-04-11 . directorsawards.hr.nih.gov.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Joyonna Gamble-George".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.